PETRA PHARMA CORP

Profile

Company Names

PETRA PHARMA CORP

Addresses

450 EAST 29TH ST., SUITE 506, NEW YORK, NY 10016

450 E 29TH ST., SUITE 506, NEW YORK, NY 10016

430 EAST 29TH STREET, SUITE 835, NEW YORK, NY 10016

430 EAST 29TH STREET, NEW YORK, NY 10016

Phone Numbers

(206) 957-7300
646-440-9210

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$58,750,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2018-08-30 
$27,545,484.00 
$27,545,484.00 
$0.00 
Debt 
1
2015-12-23 
$31,204,516.00 
$48,250,000.00 
$17,045,484.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BARBARA 
 
DALTON 
DIRECTOR
JENNA 
 
FOGER 
DIRECTOR
THONG 
 
LE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
DAVID 
 
MCELLIGOTT 
EXECUTIVE OFFICER, PROMOTER
BRIAN 
 
O-CALLAGHAN 
EXECUTIVE OFFICER, DIRECTOR
LINDSAY 
 
RAYLE 
EXECUTIVE OFFICER, PROMOTER
DAVID 
 
RENAS 
EXECUTIVE OFFICER
DAVID 
 
SCHUBERT 
EXECUTIVE OFFICER, PROMOTER
MISTI 
 
USHIO 
DIRECTOR
ALBERT 
 
YU 
EXECUTIVE OFFICER, PROMOTER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-08-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-08-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-08-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-08-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-08-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#